Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Schuitemaker

Showing results (11-20 of 92) with videos related to

Pageof 10
Sort By:
Virology|February 9, 2000
Susceptibility of in vitro stimulated PBMC to infection with NSI HIV-1 is associated with levels of CCR5 expression and beta-chemokine productionH Blaak, L J Ran, R Rientsma, et al.
European Journal of Immunology|October 1, 1992
Effects of HIV-1 Tat protein on human T cell proliferationL Meyaard, S A Otto, H Schuitemaker, et al.
Journal of Virology|January 1, 1995
Equal levels of gp120 retention and neutralization resistance of phenotypically distinct primary human immunodeficiency virus type 1 variants upon soluble CD4 treatmentM Groenink, J P Moore, S Broersen, et al.
Journal of Clinical Microbiology|April 1, 1995
Simple determination of human immunodeficiency virus type 1 syncytium-inducing V3 genotype by PCRR A Fouchier, M Brouwer, S M Broersen, et al.
Virology|May 1, 1996
Broader tropism and higher cytopathicity for CD4+ T cells of a syncytium-inducing compared to a non-syncytium-inducing HIV-1 isolate as a mechanism for accelerated CD4+ T cell decline in vivoR A Fouchier, L Meyaard, M Brouwer, et al.
Journal of Virology|October 3, 2001
Cytopathic effects of non-syncytium-inducing and syncytium-inducing human immunodeficiency virus type 1 variants on different CD4(+)-T-cell subsets are determined only by coreceptor expressionD Kwa, J Vingerhoed, B Boeser-Nunnink, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 8, 1999
CC chemokine receptor 5 cell-surface expression in relation to CC chemokine receptor 5 genotype and the clinical course of HIV-1 infectionA M de Roda Husman, H Blaak, M Brouwer, et al.
The Journal of Infectious Diseases|August 11, 1998
Emergence of syncytium-inducing human immunodeficiency virus type 1 variants coincides with a transient increase in viral RNA level and is an independent predictor for progression to AIDSI Spijkerman, F de Wolf, M Langendam, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 22, 1998
Prostaglandin E2 induces the final maturation of IL-12-deficient CD1a+CD83+ dendritic cells: the levels of IL-12 are determined during the final dendritic cell maturation and are resistant to further modulationP Kaliński, J H Schuitemaker, C M Hilkens, et al.
The Journal of Infectious Diseases|March 14, 1998
In vitro replication kinetics of human immunodeficiency virus type 1 (HIV-1) variants in relation to virus load in long-term survivors of HIV-1 infectionH Blaak, M Brouwer, L J Ran, et al.
Pageof 10

Showing results (11-20 of 92) with videos related to

Sort By:
Pageof 10
Virology|February 9, 2000
Susceptibility of in vitro stimulated PBMC to infection with NSI HIV-1 is associated with levels of CCR5 expression and beta-chemokine productionH Blaak, L J Ran, R Rientsma, et al.
European Journal of Immunology|October 1, 1992
Effects of HIV-1 Tat protein on human T cell proliferationL Meyaard, S A Otto, H Schuitemaker, et al.
Journal of Virology|January 1, 1995
Equal levels of gp120 retention and neutralization resistance of phenotypically distinct primary human immunodeficiency virus type 1 variants upon soluble CD4 treatmentM Groenink, J P Moore, S Broersen, et al.
Journal of Clinical Microbiology|April 1, 1995
Simple determination of human immunodeficiency virus type 1 syncytium-inducing V3 genotype by PCRR A Fouchier, M Brouwer, S M Broersen, et al.
Virology|May 1, 1996
Broader tropism and higher cytopathicity for CD4+ T cells of a syncytium-inducing compared to a non-syncytium-inducing HIV-1 isolate as a mechanism for accelerated CD4+ T cell decline in vivoR A Fouchier, L Meyaard, M Brouwer, et al.
Journal of Virology|October 3, 2001
Cytopathic effects of non-syncytium-inducing and syncytium-inducing human immunodeficiency virus type 1 variants on different CD4(+)-T-cell subsets are determined only by coreceptor expressionD Kwa, J Vingerhoed, B Boeser-Nunnink, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 8, 1999
CC chemokine receptor 5 cell-surface expression in relation to CC chemokine receptor 5 genotype and the clinical course of HIV-1 infectionA M de Roda Husman, H Blaak, M Brouwer, et al.
The Journal of Infectious Diseases|August 11, 1998
Emergence of syncytium-inducing human immunodeficiency virus type 1 variants coincides with a transient increase in viral RNA level and is an independent predictor for progression to AIDSI Spijkerman, F de Wolf, M Langendam, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 22, 1998
Prostaglandin E2 induces the final maturation of IL-12-deficient CD1a+CD83+ dendritic cells: the levels of IL-12 are determined during the final dendritic cell maturation and are resistant to further modulationP Kaliński, J H Schuitemaker, C M Hilkens, et al.
The Journal of Infectious Diseases|March 14, 1998
In vitro replication kinetics of human immunodeficiency virus type 1 (HIV-1) variants in relation to virus load in long-term survivors of HIV-1 infectionH Blaak, M Brouwer, L J Ran, et al.
Pageof 10